Exosomes are naturally occurring biocompatible, low immunogenic nanovesicles that can deliver genetic material with high specificity to target tissues. In addition, exosomes can be seamlessly ...

Stem cell therapy is emerging as a potential treatment for different conditions in endocrinology, including diabetes and ...

This segment also supports customers across various aspects of design, development, and manufacturing, including particle engineering ... exosome-based therapies, as well as viral vector gene ...

Addressing challenges such as the rapid elimination of natural exosomes in vivo and the limitation of drug concentration can be effectively achieved through various strategies, including engineering ...

gene expression factors and other factors all affect EXOs production (Liu and Su, 2019). Therefore, it is of great significance for its practical application in the future to increase its output ...

Cancer and Stem Cell Biology Laboratory, Department of Genetic Engineering, SRM Institute of Science and Technology, Kattankulathur, Chengalpattu District, Tamil Nadu-603203, India ...

Much like a Swiss Army knife, mvGPT is a marvel of compact engineering—a genetic powerhouse of versatility and precision. As highlighted in a study by Rice University, the potential of mvGPT ...

Developmental biologist Zhi-kun Li of the Chinese Academy of Sciences, first author of the new study, said it represents "a notable accomplishment in mammalian genetic engineering." He said the ...

Researchers developed a new gene-editing strategy that dramatically boosts the effectiveness of gene therapies in the liver, a breakthrough that could lead to new treatments for about 700 genetic ...

This expertise positions MaxCyte to support both ex vivo and in vivo cell and gene therapy developers in the process development stage through standardization of the cell engineering workflow.

Evo 2 now includes information from humans, plants, and other eukaryotic species to expand its capabilities in generative functional genomics.

Dec. 10, 2024 — In a single IV injection, a gene therapy targeting cBIN1 can reverse the effects of heart failure and restore heart function in a large animal model. The therapy increases the ...